Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 14Carcinoma, Basal Cell 7Bowen's Disease 2Warts 1Skin Neoplasms 1Skin Diseases 1Neoplasms, Basal Cell 1Keratosis 1Connective Tissue Diseases 1Carcinoma, Squamous Cell 1Carcinoma 1

Interventions

pembrolizumab 8Nivolumab 4fludarabine 2Cyclophosphamide 2sonidegib 1obinutuzumab 1methyl 5-aminolevulinate 1lutetium Lu 177 dotatate 1fludarabine phosphate 1durvalumab 1daromun 1cabozantinib 1avelumab 1atezolizumab 1advexin 1Tomography, Optical Coherence 1Therapeutics 1Taxes 1Specimen Handling 1Radiotherapy 1ProMune 1Pemetrexed 1Paclitaxel 1Oncolytic Virotherapy 1Mesna 1Magnetic Resonance Spectroscopy 1MAPRE1 protein, human 1Lutetium-177 1Interleukin-2 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × methyl 5-aminolevulinate × Dermatologic × Clear all
NCT00535080 2021-02-18

Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease

Galderma R&D

No longer available
Dermatologic

Bowen's Disease, Carcinoma, Carcinoma, Basal Cell, Keratosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡